Skip to main content

Table 2 Qualitative analysis of the projects

From: How to promote adverse drug reaction reports using information systems – a systematic review and meta-analysis

Variable

Time period

Total (%)

Project numbers

<2004 (4 projects)

2005–2007 (4 projects)

2008–2010 (8 projects)

2011–2013 (13 projects)

Geographic area covered by the project

      

 Regional

4

3

5

6

18 (62)

2, 4, 5, 7, 8, 10, 11, 13, 14, 16, 17, 20, 21, 22, 26, 27, 28, 29

 National

0

1

3

6

10 (34)

1, 3, 6, 9, 15, 18, 19, 23, 24, 25

 International

0

0

0

1

1 (3)

12

Area covered by the project

      

 Hospital

4

2

5

4

15 (52)

2, 4, 5, 8, 11, 13, 17, 18, 20, 21, 22, 26, 27, 28, 29

 Community

0

0

0

6

6 (21)

1, 3, 12, 14, 15, 16

 Primary care

0

2

1

1

4 (14)

6, 7, 9, 10

 Other healthcare institutions (different from hospitals or primary care)

0

0

1

2

3 (10)

19, 24, 25

 Clinical trials

0

0

1

0

1 (3)

23

Type of action promoted by the project

      

 Passive promotion of ADR reporting

3

3

6

10

22 (76)

4, 5, 6, 8, 9, 10, 11, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 29

 Active promotion of ADR reporting

1

1

2

3

7 (24)

1, 2, 3, 7, 12, 13, 28

Type of software

      

 Web-based

1

3

6

6

16 (55)

2, 3, 5, 7, 9, 12, 13, 14, 15, 16, 19, 20, 22, 23, 27, 28

 System inside the Electronic Health Record

3

1

2

6

12 (41)

4, 6, 8, 10, 11, 17, 21, 24, 25, 26, 18, 29

 Mobile

0

0

0

1

1 (3)

1

Type of institution promoting the study

      

 Hospital

2

1

3

3

9 (31)

2, 4, 8, 17, 18, 21, 26, 27, 29

 University

1

1

3

4

9 (31)

5, 10, 11, 12, 13, 19, 20, 24, 25

 National institution

0

2

0

2

4 (14)

1, 9, 15, 22

 Regulatory authority

1

0

1

3

5 (17)

6, 7, 14, 16, 28

 Othera

0

0

1

1

2 (7)

3, 23

Target

      

 Healthcare professionals

4

2

7

8

21 (72)

4, 6, 7, 8, 9, 10, 11, 13, 14, 16, 17, 18, 19, 21, 23, 24, 25, 26, 27, 28, 29.

 Patients

0

2

1

4

7 (24)

1, 2, 3, 5, 12, 20, 22

 Healthcare professionals and patients

0

0

0

1

1 (3)

15

Type of medicine

      

 All

4

1

5

11

21 (72)

3, 4, 5, 6, 7, 8, 9, 11, 12, 14, 16, 17, 18, 19, 20, 21, 24, 25, 26, 28, 29

 Vaccines

0

2

1

2

5 (17)

1, 10, 13, 15, 22

 Chemotherapy

0

1

0

0

1 (3)

2

 Human albumin

0

0

1

0

1 (3)

23

 Radiopaque agents

0

0

1

0

1 (3)

27

Type of ADR

      

 All

4

4

8

11

27 (93)

2, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29

 Serious

0

0

0

2

2 (7)

1, 3

  1. a Other institutions are: Clinical trial team (project 23) and website producer (project 3)